Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
Chemical

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021

  • By ICN Bureau | May 15, 2021

Dr. Reddy's Laboratories has reported total income of Rs.4850.8 crores during the period ended March 31, 2021 as compared to Rs.5012.4 crores during the period ended December 31, 2020. The company reported total income of Rs.4522.5 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.557.3 crores for the period ended March 31, 2021 as against net profit of Rs.27.9 crores for the period ended December 31, 2020. The company has posted net profit of Rs.781.1 crores for the period ended March 31, 2020.

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during the 12 months period ended March 31, 2021 as compared to Rs.18137.6 crores during the 12 months period ended March 31, 2020.

The company has posted net profit of Rs.1951.6 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.2026 crores for the 12 months period ended March 31, 2020.

The company has reported EPS of Rs.117.34 for the 12 months period ended March 31, 2021 as compared to Rs.121.99 for the 12 months period ended March 31, 2020.

Commenting on the results, G V Prasad, Co-Chairman & MD, said "In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline. We are prioritizing our efforts to launch Sputnik V vaccine across India while working on the development and commercialization of several drugs for the treatment of mild to severe COVID 19 infections."

 

Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport

Upcoming Conferences

Chem Connect 2025

August 21, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization